RVS.AX - Revasum, Inc.

ASX - ASX Delayed Price. Currency in AUD
1.3500
+0.0500 (+3.85%)
At close: 1:19PM AEST
Stock chart is not supported by your current browser
Previous Close1.3000
Open1.3500
Bid1.3000 x 0
Ask1.3500 x 0
Day's Range1.3500 - 1.3500
52 Week Range1.2550 - 2.0000
Volume500
Avg. Volume70,354
Market Cap103.337M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.6660
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswirelast month

    Firsthand Technology Value Fund Discloses Top Portfolio Holdings

    Firsthand Technology Value Fund, Inc. (SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of February 28, 2019, were Revasum, Pivotal Systems, IntraOp Medical, Phunware, and QMAT.

  • GlobeNewswire3 months ago

    Firsthand Technology Value Fund Discloses Preliminary NAV of $26.55 Per Share as of December 31, 2018

    Firsthand Technology Value Fund, Inc. (SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its preliminary NAV, as of December 31, 2018, was $26.55. The Fund further announced that its top five holdings as of December 31, 2018, were Revasum, Pivotal Systems, IntraOp Medical, Phunware, and QMAT. As of December 31, 2018, the Fund’s investment in Revasum consisted of 53,834,340 shares of restricted common stock and common stock equivalents and represented approximately 30.8% of the Fund’s preliminary net assets.

  • We're sorry this is all we were able to find about this topic.